Alcista
$0.42
Precio del escenario
$1.850
+0.263 (+14.20%)Al cierre
Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers.
Biomx Inc (PHGE) is currently not a strong buy due to its significant losses and lack of revenue. The stock is trading at $0.15, down 93.10% year-to-date, indicating severe financial distress. Although the recent acquisition news may provide some positive outlook, the company reported a net income loss of $37.72 million in Q2 2026, which raises concerns about its financial stability. The RSI is at 66.55, suggesting it is nearing overbought territory, which could lead to a pullback. The main risk is the ongoing negative earnings trend, with a forward P/E ratio of 0, indicating no expected profitability in the near future.
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

BiomX to Rebrand as Tessera, Launches No-Code AI Command Platform

BiomX to Rebrand as Tessera Defense and Homeland Security Inc.

BiomX Subsidiary Secures $300,000 Defense Order

BiomX Acquires 10% Stake in Motomea to Enhance Drone Testing Capabilities

BiomX Amends Terms of Zorronet Acquisition
Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers. It operates in the Healthcare sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).
Biomx Inc (PHGE) is currently not a strong buy due to its significant losses and lack of revenue. The stock is trading at $0.15, down 93.10% year-to-date, indicating severe financial distress. Although the recent acquisition news may provide some positive outlook, the company reported a net income loss of $37.72 million in Q2 2026, which raises concerns about its financial stability. The RSI is at 66.55, suggesting it is nearing overbought territory, which could lead to a pullback. The main risk is the ongoing negative earnings trend, with a forward P/E ratio of 0, indicating no expected profitability in the near future.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.